TAXIS Pharmaceuticals

545 posts

TAXIS Pharmaceuticals banner
TAXIS Pharmaceuticals

TAXIS Pharmaceuticals

@TAXISPharma

Biotech developing novel antibacterial therapies to combat antimicrobial resistance, targeting resistance mechanisms in drug-resistant pathogens.

Katılım Nisan 2026
187 Takip Edilen15 Takipçiler
TAXIS Pharmaceuticals retweetledi
TAXIS Pharmaceuticals
TAXIS Pharmaceuticals@TAXISPharma·
Identifying #antimicrobialstewardship challenges is only the start. Implementing sustainable changes in #prescribing, #diagnostics, workflows, and clinical behavior across #healthcare systems can be more complex. #AntimicrobialResistance #AMR #Antibiotics #AntibioticResistance
Craig Joseph, MD@CraigJoseph

This article is a nice overview of #deimplementation and how it relates to antimicrobial and diagnostic stewardship. Step 1 - identify the problem. We're ok at this step, in my experience. It's the other steps that are tricky! buff.ly/3Nqayba

English
0
1
1
10
TAXIS Pharmaceuticals
TAXIS Pharmaceuticals@TAXISPharma·
Innovation across multiple scientific fields will be critical in the fight against antimicrobial resistance. Promising direction for future AMR strategies. #AMR #AntimicrobialResistance
Working to Fight AMR@WeFightAMR

In @SciTechDaily1, researchers have developed a low-cost sulfur-based material that can kill drug-resistant bacteria and fungi without harming human cells, pointing to a promising new approach to combating antimicrobial resistance. Learn more: scitechdaily.com/scientists-dis…

English
0
2
3
73
TAXIS Pharmaceuticals retweetledi
Medscape
Medscape@Medscape·
Antibiotics are among the most effective treatments available in modern medicine, but inappropriate prescriptions continue to accelerate antimicrobial resistance. Every decision to prescribe an antibiotic should be evidence-based and guided by established recommendations. Antibiotic stewardship programs have shown that structured prescribing approaches can improve the quality of care and clinical outcomes. Rational antibiotic prescription involves more than choosing the correct drug. Appropriate indication, treatment duration, antibiotic selection, and ongoing monitoring are crucial. Consistently applying these principles supports evidence-based, patient-centered treatment and makes an effective contribution to the fight against antibiotic resistance. Tap the link in to learn how these principles can be effectively applied in daily clinical practice. mdsc.pe/4fvp3Z9
Medscape tweet media
English
1
8
15
1.5K
TAXIS Pharmaceuticals retweetledi
COPPTECH
COPPTECH@copptech·
Copptech™ technology is not only effective, but also long-lasting, designed to offer antimicrobial protection throughout their entire lifespan. La tecnología de Copptech™ no solo es efectiva, sino también duradera, diseñada para ofrecer protección a lo largo de su vida útil.
COPPTECH tweet media
Español
0
1
0
20
TAXIS Pharmaceuticals retweetledi
Contagion
Contagion@Contagion_Live·
This Memorial Day, Contagion Live honors and remembers the courageous individuals who made the ultimate sacrifice while serving our nation. We reflect on their legacy with gratitude and respect today and always.
Contagion tweet media
English
0
3
3
66
TAXIS Pharmaceuticals
TAXIS Pharmaceuticals@TAXISPharma·
Important discussions and an important reminder that AMR preparedness cannot wait. Sustained investment in scientific innovation, diagnostics, stewardship, surveillance infrastructure, and collaborative public-private partnerships will be essential to global health security.
Global Antibiotic R&D Partnership (GARDP)@gardp_amr

At #WHA79, GARDP joined critical conversations, shaping the global response to antimicrobial resistance. From a @reactgroup roundtable calling for funded National Action Plans, accountable systems and LMIC representation at the heart of decision-making, to a @Roche & @MedsPatentPool discussion on anticipatory investment and long-term public-private collaboration — the week underscored that innovation, access and stewardship must be treated as global public goods. Thank you to @EC_HERA , @pahowho, ReAct, Roche, MPP and all partners championing collective action against #AMR. #AMR #WorldHealthAssembly #AntibioticResistance #GlobalHealth

English
0
0
2
12
TAXIS Pharmaceuticals
TAXIS Pharmaceuticals@TAXISPharma·
@gardp_amr @reactgroup @Roche Important discussions and an important reminder that AMR preparedness cannot wait. Sustained investment in scientific innovation, diagnostics, stewardship, surveillance infrastructure, and collaborative public-private partnerships will be essential to global health security.
English
0
0
2
3
Global Antibiotic R&D Partnership (GARDP)
Global Antibiotic R&D Partnership (GARDP)@gardp_amr·
At #WHA79, GARDP joined critical conversations, shaping the global response to antimicrobial resistance. From a @reactgroup roundtable calling for funded National Action Plans, accountable systems and LMIC representation at the heart of decision-making, to a @Roche & @MedsPatentPool discussion on anticipatory investment and long-term public-private collaboration — the week underscored that innovation, access and stewardship must be treated as global public goods. Thank you to @EC_HERA , @pahowho, ReAct, Roche, MPP and all partners championing collective action against #AMR. #AMR #WorldHealthAssembly #AntibioticResistance #GlobalHealth
Global Antibiotic R&D Partnership (GARDP) tweet mediaGlobal Antibiotic R&D Partnership (GARDP) tweet mediaGlobal Antibiotic R&D Partnership (GARDP) tweet media
English
2
0
2
755
TAXIS Pharmaceuticals retweetledi
TAXIS Pharmaceuticals
TAXIS Pharmaceuticals@TAXISPharma·
#Antimicrobialresistance is not just a scientific challenge, it is also a behavioral one. How #antibiotics are used across clinical, community, and agricultural settings plays a major role in how quickly #resistance develops and spreads. #AMR #AntibioticResistance #WorldHealth
NextGen Antimicrobial Stewards Initiative NASI@nextgen_nasi

Antibiotics are losing their power. And the scary part? This is happening faster than many people realize. Full webinar now available on YouTube. youtu.be/ye_5cv46mN8 #AMR #AntibioticResistance #HealthInnovation #PublicHealthAwareness

English
0
2
3
46
TAXIS Pharmaceuticals
TAXIS Pharmaceuticals@TAXISPharma·
@WeFightAMR @SciTechDaily1 Promising research highlighting alternative approaches to combating AMR. As resistant bacterial and fungal infections continue to rise, innovation across materials science, microbiology, diagnostics, and therapeutics will all be important in expanding the tools available.
English
0
0
0
2
TAXIS Pharmaceuticals retweetledi
Global Antibiotic R&D Partnership (GARDP)
Global Antibiotic R&D Partnership (GARDP)@gardp_amr·
Thank you, Director Barbosa, for taking the time to meet with our Deputy Director Dr. Peter Beyer at #WHA79. Improving access to effective antibiotics and building a stronger AMR response in the Americas is urgent work and PAHO's leadership in the region is critical to making that happen. We look forward to continuing to build on this collaboration with PAHO. @DirOPSPAHO I @pahowho
Jarbas Barbosa@DirOPSPAHO

During #WHA79, I met with Dr. Peter Beyer, Deputy Director of the @gardp_amr, to continue advancing collaboration on improving access to existing and new antibiotics and strengthening the response to AMR in the Americas 🌎

English
0
1
3
269

Keşfet

@gardp_amr @reactgroup @Roche @MedsPatentPool @EC_HERA @pahowho @CDCgov @WeFightAMR